LOCAL ANESTHESIA DRUGS MARKET ANALYSIS
Recent Developments:
In May 2021, Heron Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ZYNRELEF (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty.
In August 2020, B. Braun Melsulgen AG and Royal Philips announced that Onvision needle tip tracking technology for regional anesthesia got the 501(k) clearance from the United States Food and Drug Administration (USFDA).
In January 2020, Pacira BioSciences, Inc. announced a collaboration with Envision Physician Services to train anesthesiology clinicians on ultrasound-guided regional anesthesia techniques using long-acting local anesthetics via a series of interactive workshops. The program supports ongoing efforts to advance the delivery of high-quality, patient-centered care.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
